Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: Implications for the immunotherapy of cancer

Journal of Immunotherapy

Volumn 14, Issue 2, 1993, Pages 155-161

  Zeh, H J ^a   Hurd, S ^a   Storkus, W J ^a   Lotze, M T ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Immune effectors; Interleukin 12; Lymphokine activated killer cells; Natural killer cells

Indexed keywords

CYTOKINE;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CANCER; CANCER IMMUNOTHERAPY; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; GROWTH SUBSTANCES; HUMAN; IMMUNOTHERAPY; INTERLEUKIN-12; INTERLEUKINS; KILLER CELLS, LYMPHOKINE-ACTIVATED; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASMS; PHYTOHEMAGGLUTININS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR;

EID: 0027483008     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199308000-00012     Document Type: Article

References (20)

1. Gately M, Wilson D, Wong H. Synergy between recombinant interleukin-2 and IL-2 depleted lymphokine-containing supernatents in facilitating allogenic human cytolytic T lymphocyte responses in vitro. J Immunol 1986;136:1274-81.
2. Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-12.
3. Gubler U, Chua AO, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88:4143-7.
4. Merberg DM, Wolf SF, Clark SC. Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today 1992;13:77-8.
5. Gearing DP, Cosman D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with extracellular domain of the interleukin-6 receptor. Cell 1991;66:9-10.
6. D’Andrea A, Rengaraju M, Vahante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1378-98.
7. Chizzonite R, Truitt T, Desai BB, et al. IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. J Immunol 1992;148:3117-24.
8. Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK. IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992;148:3125-32.
9. Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1992;147:874-82.
10. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF): a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989:170:827-45.
11. Manetti R, Parronchi P, Giudizi M, et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type I (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
12. Chan S, Perussia B, Gupta J, et al. Induction of IFN-gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other in-ducers. J Exp Med 1991;173:869-79.
13. Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-12.
14. Hurd S, Martin DS, Storkus WJ, Maeur M, Lotze MT. Correlation of specific peptide usage and TCR variable region usage. J Immunol (in press).
15. Storkus WH, Zeh HJ III, Maeurer MJ, Salter RJ, Lotze MT. Isolation of human melanoma peptides recognized by class I restricted tumor infiltrating lymphocytes. J Immunol (in press).
16. Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1992;147:874-82.
17. Gately M, Wolitzky A, Quinn P, Chizzonite R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 1992;143:127-42.
18. Rosenburg SA, Packard B, Aebersold P, et al. Use of tumorinfiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. New Engl J Med 1988;319:1676-80.
19. Lotze MT. Interleukin-2. In: Devita VT, Hellman S, Rosenberg SA, eds. Basic principles in the biologic therapy of cancer. Philadelphia: JB Lippincott, 1991:123-42.
20. +T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.